OBJECTIVE: To evaluate whether insulin pump therapy [continuous subcutaneous insulin infusion (CSII)] is associated with a lower frequency of disordered eating, better glycemic control, and improved quality of life and self-efficacy compared to multiple daily injections (MDI) in adolescent females with type 1 diabetes mellitus (T1DM). METHODS: This cross-sectional study included 22 adolescent females using CSII and 47 adolescent females using MDI who completed standardized questionnaires measuring disordered eating, quality of life, and self-efficacy. Most recent glycosylated hemoglobin (HbA1(c)) and measures of personal characteristics were drawn from medical records. RESULTS: The CSII group exhibited better glycemic control and reported higher quality of life and more self-efficacy. However, the groups did not differ significantly on disordered eating behaviors and attitudes. CONCLUSION: Insulin pump therapy may provide a means for improving glycemic control, quality of life, and self-efficacy in adolescent females with type 1 diabetes.
OBJECTIVE: To evaluate whether insulin pump therapy [continuous subcutaneous insulin infusion (CSII)] is associated with a lower frequency of disordered eating, better glycemic control, and improved quality of life and self-efficacy compared to multiple daily injections (MDI) in adolescent females with type 1 diabetes mellitus (T1DM). METHODS: This cross-sectional study included 22 adolescent females using CSII and 47 adolescent females using MDI who completed standardized questionnaires measuring disordered eating, quality of life, and self-efficacy. Most recent glycosylated hemoglobin (HbA1(c)) and measures of personal characteristics were drawn from medical records. RESULTS: The CSII group exhibited better glycemic control and reported higher quality of life and more self-efficacy. However, the groups did not differ significantly on disordered eating behaviors and attitudes. CONCLUSION: Insulin pump therapy may provide a means for improving glycemic control, quality of life, and self-efficacy in adolescent females with type 1 diabetes.
Authors: Claire M Peterson; Deborah Young-Hyman; Sarah Fischer; Jessica T Markowitz; Andrew B Muir; Lori M Laffel Journal: J Pediatr Psychol Date: 2018-01-01
Authors: Deborah L Young-Hyman; Claire M Peterson; Sarah Fischer; Jessica T Markowitz; Andrew B Muir; Lori M Laffel Journal: J Diabetes Sci Technol Date: 2016-06-28
Authors: Jessica T Markowitz; Cielo A Alleyn; Roxanne Phillips; Andrew Muir; Deborah Young-Hyman; Lori M B Laffel Journal: Diabetes Technol Ther Date: 2013-04-03 Impact factor: 6.118
Authors: Jason Van Allen; Amy E Noser; Andrew K Littlefield; Paige L Seegan; Mark Clements; Susana R Patton Journal: J Pediatr Psychol Date: 2018-03-01